A clinician and dedicated researcher in healthcare epidemiology, infection prevention, and antibiotic stewardship, Dr. Calfee has served as an associate editor of the journal over the past several years.
Dr. Roy M. Gulick and colleagues have received a renewal from the NIAID in support of their HIV CTU grant in the amount of $18.9 million through 2027. The renewal provides funding for the AIDS Clinical Trials Group and HIV Prevention Trials Network.
Dr. Brad Jones, Division of Infectious Diseases, began a collaboration several years ago involving T-cell therapy approaches to HIV that has played a key role in a breakthrough study on COVID-19.
The WDOM congratulates three of its faculty - Drs. Julie Magarian Blander, Robert Peck, and Erica Phillips - who received grants from Weill Cornell Medicine in support of their innovative research on COVID-19.
A development program for junior faculty, LAMP provides participants with critical tools to accomplish their primary career goals as academicians in the field of medicine.
Until a vaccine is discovered and implemented for COVID-19, WDOM physicians on the frontlines continue to focus on diagnosis, drug treatment options, and best practices.
The guidelines will draw on the knowledge of a panel of experts and will be updated frequently with scientific evidence and data to inform clinicians on how to best manage patients with COVID-19.
Tens of thousands of people are expected to become sick with COVID-19 in Haiti.
Physicians and scientists in the WDOM are forging much-needed clinical trials for the treatment of COVID-19. Several lines of research are underway.
In response to the COVID-19 pandemic, faculty from across the Weill Department of Medicine have been pursuing critical research.